Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
spirit
NULL
-
starch
NULL
-
sulfur ointment (for use only as a base combined with active ingredients)
NULL
-
sulfur precipitated
NULL
-
sulthiame
OSPOLOT
-
syrup
NULL
-
talaporfin sodium
LASERPHYRIN
-
talazoparib tosilate
TALZENNA
-
talc purified, sterilised
NULL
-
tasurgratinib succinate
TASFYGO
-
tecovirimat hydrate
TEPOXX
-
tegafur/gimeracil /oteracil potassium
TS-1 PARTIAL CHANGE APPROVAL
-
teneligliptin hydrobromide hydrate
TENELIA
-
tepotinib hydrochloride hydrate
TEPMETKO
-
tetracosactide
SYNACTHEN DEPOT 1 MG/1 ML
-
thymol
NULL
-
thymol compound mouth wash
NULL
-
tiotropium bromide hydrate/olodaterol hydrochloride
SPIOLTO
-
tirabrutinib hydrochloride
VELEXBRU INITIAL APPROVAL
-
tixagevimab and cilgavimab
EVUSHELD (NOTE 2)
-
tolvaptan sodium phosphate
SAMTASU
-
topiroxostat
TOPILORIC/URIADEC
-
trafermin
REGROTH
-
tragacanth compound powder
NULL
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.